HDX-MS takes centre stage at unravelling kinase dynamics
K Lorenzen, T Pawson - Biochemical Society Transactions, 2014 - portlandpress.com
In recent years, HDX-MS (hydrogen–deuterium exchange coupled to MS) on biomolecules
has evolved from a niche technique to a powerful method in the investigation of protein …
has evolved from a niche technique to a powerful method in the investigation of protein …
Molecular targeted therapy, advanced treatment for cancers of the head-and-neck region: A systematic review
F Shaikh, SK Sodhi, LM Kale, ZF Farooqui… - Journal of Cancer …, 2023 - journals.lww.com
Aim: The aim of the study is to carry out a systematic review of clinical trials of molecular
targeted therapy in the treatment of cancer. Objective: The objective of the study is to …
targeted therapy in the treatment of cancer. Objective: The objective of the study is to …
Vascular endothelial growth factor–targeted paclitaxel‐loaded liposome microbubbles and inhibition of human epidermoid‐2 cell proliferation
L Zhou, W Luo - Head & Neck, 2017 - Wiley Online Library
Background Vascular endothelial growth factor (VEGF) plays an important role in the
formation of capillary blood vessels. The purpose of this study was to evaluate the inhibitory …
formation of capillary blood vessels. The purpose of this study was to evaluate the inhibitory …
Dysregulation of ß‐catenin, WISP1 and TCF21 predicts disease‐specific survival and primary response against radio (chemo) therapy in patients with locally …
E Vyskocil, J Pammer, G Altorjai, MC Grasl… - Clinical …, 2019 - Wiley Online Library
Objective The objective of this study was to determine the prognostic and predictive impact
of β‐catenin, TCF21 and WISP1 expression in patients with squamous cell carcinomas of …
of β‐catenin, TCF21 and WISP1 expression in patients with squamous cell carcinomas of …
Current role of dacomitinib in head and neck cancer
Introduction: Recurrent and/or metastatic head and neck squamous cell carcinoma
(HNSCC) has a dismal prognosis. With the emergence of monoclonal antibodies and …
(HNSCC) has a dismal prognosis. With the emergence of monoclonal antibodies and …
Frontal sinus carcinoma in forty‐one dogs (2001–2022)
J Gedon, M Kessler, JM Schmidt - Veterinary and Comparative …, 2023 - Wiley Online Library
Reports on canine frontal sinus carcinomas (FSCs) are scarce. This retrospective review of
41 dogs with FSC (2001–2022) describes demographic and clinical characteristics of canine …
41 dogs with FSC (2001–2022) describes demographic and clinical characteristics of canine …
[图书][B] Radiotherapy and clinical radiobiology of head and neck cancer
Common factors that lead to treatment failure in head and neck cancer are the lack of tumour
oxygenation, the accelerated division of cancer cells during treatment, and radioresistance …
oxygenation, the accelerated division of cancer cells during treatment, and radioresistance …
The Effect of Canertinib on Sensitivity of Cytotoxic Drugs in Tamoxifen‐Resistant Breast Cancer Cells In Vitro
Aims and Objectives. To investigate and examine the reversal effects of canertinib on the
activity of EGFR and tamoxifen resistance in drug‐resistant human breast carcinoma cells …
activity of EGFR and tamoxifen resistance in drug‐resistant human breast carcinoma cells …
Therapeutic strategy for cancer immunotherapy in head and neck cancer
H Ishii, S Tanaka, K Masuyama - Advances in Cellular and …, 2015 - Taylor & Francis
Cancer immunotherapy is one of the new prospective treatments for head and neck
squamous cell carcinoma (HNSCC). This strategy can effectively induce anti-tumor effects …
squamous cell carcinoma (HNSCC). This strategy can effectively induce anti-tumor effects …